← All supplements
Limited evidenceImmunity

Vasaka (Adhatoda)

An Ayurvedic herb for cough and bronchitis whose alkaloid vasicine inspired the mucolytic drugs bromhexine and ambroxol. The drugs were studied; the herb itself was not.

Evidence last reviewed: August 2026

What the science says

  • Cough and mucus clearance Limited evidence

    Antitussive activity has been shown in animal models of mechanically and chemically induced coughing. There are no adequately designed randomised placebo-controlled trials of Adhatoda vasica extract in people with cough or bronchitis.

  • Its derivatives are real medicines Moderate evidence

    Vasicine from this plant was the starting point for bromhexine and ambroxol, semisynthetic mucoactive drugs with a clinical trial record reviewed in the respiratory literature. That record belongs to the purified drugs at defined doses, not to herbal vasaka preparations.

  • Bronchodilator claims Limited evidence

    A review of the botany, traditional uses and pharmacology of Adhatoda vasica describes bronchodilatory and anti-inflammatory effects in laboratory and animal work. Human confirmation is missing.

Dosage & safety

Studied doseNo validated dose. Traditional use is 5-10 mL of leaf juice or 1-3 g of dried leaf powder daily, or standardised extracts at label dose.
SafetyVasicine has uterotonic and abortifacient activity in animals, so vasaka should be avoided in pregnancy. High doses can cause nausea, vomiting and diarrhoea. Caution with anticoagulants and in people with bleeding disorders. Not recommended for young children without medical advice.

Scientific references

Where to buy

Referral link — this site may earn a commission on purchases.

Related in Immunity